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ABSTRACT 
Binding sites for atrial natriuretic factor (ANF) were determined on isolated 
rat glomeruli as well as on glomerular membranes. To define optimal 
conditions, binding of ANF was investigated varying incubation time, 
temperature and protein concentration. Binding conditions were found to 
be best at 4°C for 5 hours with 15 ßg of glomerular protein. Saturation and 
affinity cross-linking experiments confirmed the presence of two distinct 
receptor subtypes - the B-receptor (130 kDa) and the C-receptor (65 kDa). 
Quantitative differentiation of both ANF binding sites was achieved by 
competitive displacement with two different unlabeled ANF ligands: a) 
rANF(99-126) (homologous displacement), b) des(18-22)rANF(4-23)NH2 
(heterologous displacement). Intact glomeruli and glomerular membranes 
did not differ significantly in receptor density for the B-receptor (71 ± 37 vs. 
94 ± 53 fmol/mg protein) or the C-receptor (976 ± 282 vs. 966 ± 167 
fmol/mg protein) or in affinity constants for the B-receptor (43 ± 36 vs. 52 
± 44 pM) or the C-receptor (876 ± 377 vs. 307 ± 36 pM). Glomerular 
membranes compared to glomeruli showed less nonspecific binding and 
less intra-assay variation of measuring points done in triplicates. 
This method of selective displacement should allow to study the influence 
of various physiological and pathophysiological conditions on the binding 
properties of B- and C-receptors for ANF. 
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INTRODUCTION 
Atrial natriuretic factor (ANF), a peptide hormone, is released into the 
circulation by atrial cardiomyocytes (1). Its natriuretic, diuretic, vasorelaxant 
and hypotensive actions are mediated by interacting with two types of 
receptors. It has been reported that the B-receptor which is tightly coupled 
to guanylate cyclase exerts the biological effect (2) whereas the C-receptor 
presumably acts as a clearance receptor (3, 4) - its biological role, how-
ever, remains incompletely understood. Recent investigations demon-
strated a negative coupling of C-receptors to adenylate cyclase (5) 
implying a more complex biological action than merely modulating ANF 
plasma concentrations. ANF receptors have been demonstrated on a 
variety of tissues (6, 7). A major target site for ANF in the kidney seems to 
be the glomerulus (8, 9). Binding studies have employed both - intact 
glomeruli and glomerular membranes, but binding properties of both 
tissues have not been compared so far. Furthermore, as yet only few 
studies have reported quantitative binding analysis of the two distinct ANF 
receptors (4, 10, 11). Therefore, aim of this study was to define optimal 
binding conditions to quantitatively differentiate B- and C-receptors. 
MATERIALS AND METHODS 
Isolation of Glomeruli and Preparation of Glomerular Membranes 
Kidneys from male Sprague-Dawley rats (300-350 g) were used for 
tissue preparation. Glomeruli were isolated by a modified graded sieving 
method (12). Kidneys were cut longitudinally and the medulla was 
removed. All subsequent steps were performed in siliconized glassware at 
4°C. The cortical tissue was pressed through a 250 Aim stainless steel 
sieve. The fragments were collected and suspended in ice-cold phosphate-
buffered saline (PBS), pH 7.5. This material was gently filtered through a 75 
/xm nylon sieve. Tissue remaining on this sieve was recovered and filtered 
through a 140 /im nylon sieve, allowing to separate glomeruli from 
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remaining tubules. Glomeruli thus retrieved were visualized under light 
microscopy and were devoid of tubules and vessels (purity > 97%). 
Membrane preparation was then proceeded by centrifugation (10,000 g, 
4°C, 10 min). Glomeruli were resuspended in 50 mM tris(hydroxymethyl)-
aminomethane (Tris)-HCI, pH 7.4, 1mM NaHC0 3 , and homogenized with 
a Polytron (Kinematica, Littau, Switzerland), at 4°C, setting 6 for 3 x 20s. 
The homogenate was diluted (1:1) with 50 mM Tris-HCI, pH 7.4, 1mM 
EDTA, 1mM MgCI 2 and sedimented at 30,000 g for 15 min at 4°C. The 
pellet was washed once and resuspended in 50 mM Tris*HCI, pH 7.4, 250 
mM sucrose. The membranes were frozen and stored at -70°C. Protein 
concentration was determined by the method of Lowry et al. (13) using 
bovine serum albumin as standard. 
Binding Assay 
To define optimal conditions, binding studies were performed in 
dependance of incubation time, temperature and protein concentration. 
Finally 15 ^g of glomerular protein were incubated in triplicates with 20 pM 
1 2 5 l - r A N F (specific activity 2.200 Ci/mmol, Biotrend, Köln, W. Germany) at 
4°C for 5 h in a final volume of 0.5 ml. The assay buffer contained: 50 mM 
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes), pH 7.5, 5 
mM MgCI 2 , 0.2% bovine serum albumin (BSA), 0 .1% bacitracin and the 
following protease inhibitors: 4 /iM aprotinin, 8 jug/nnl phosphoramidon, 2 
Mg/ml bestatin, 40 ßg/rr\\ chymostatin (Sigma, Deisenhofen, W. Germany). 
For competitive binding studies (triplicates) the unlabeled peptides a) 
rANF(99-126) (Novabiochem, Läufelfingen, Switzerland) or b) des(18-
22)rANF(4-23)NH 2, a truncated ANF analogue that binds to C-receptors 
only (4), were present in increasing concentrations (10~ 1 2-10~ 6 M). 
Displacement with these two unlabeled ANF peptides as well as 
displacement of 1 2 5 l - r A N F by unlabeled rANF(99-126) in presence of 10~6 
M des(18-22)rANF(4-23)NH2 allowed for differentiation of both receptor 
types. Saturation experiments contained 10-2.000 pM 1 2 5 l - rANF . 
Nonspecific binding was determined in presence of 10" 6 M rANF(99-126). 
Reactions were stopped by adding 2.5 ml ice-cold 50 mM Tris- HCl, pH 7.4 
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and rapid filtration through 1% polyethyleneimine-treated Whatman GF/C 
filters. Filters were washed with 5 ml 50 mM Tris-HCI, pH 7.4, allowed to 
dry, and radioactivity was measured in an LKB 1261 Multigamma counter 
(Turku, Finland) with 80% efficiency. 
Affinity Cross-linking of ANF Receptors 
30 /xg glomerular membrane protein were incubated for 5 h at 4°C 
with 60 pM 1 2 5 l-rANF(99-126) in the presence or absence of unlabeled 
rANF(99-126). After incubation, the membranes were washed, re-
suspended in ice-cold PBS-buffer, pH 7.5 and incubated with 0.1 mM 
bis(sulfosuccinimidyl)suberate in PBS or 0.2 mM disuccinimidyl suberate in 
dimethylsulfoxide (Pierce, Beijerland, Netherlands) for 25 min at 4°C. The 
reaction was quenched by adding 10 mM ammonium acetate and the 
membranes were centrifuged in an Eppendorf centrifuge for 7 min. The 
pellet was resuspended in 30 Mi sample buffer (62 mM Tris«HCI, pH 6.8, 
2% SDS, 10% glycerol, 0.001% bromphenol blue) containing 5% 2-
mercaptoethanol and heated for 3 min at 100°C. The membranes were 
resolved on a 7.5% sodium dodecyl sulfate (SDS) Polyacrylamide gel 
under constant voltage conditions (Hoefer Scientific Instruments, San 
Francisco, USA). Standard molecular weight markers were used for 
calculation of molecular weights of labeled bands (Serva, Heidelberg, W. 
Germany). Gels were stained, dried and exposed to Kodak X-OMAT AR 
film with a Kodak X-OMAT regular enhancing screen at -70°C for 14 days. 
Analysis of Data 
The results are expressed as mean ± SE for separate experiments. 
Saturation experiments were analyzed by ENZFITTER (Elsevier, BIOSOFT, 
Cambridge, United Kingdom). Data from competitive displacement curves 
were analyzed with the LIGAND program, based on a nonlinear least-
squares curve-fitting (14). According to a model of two independent 
classes of binding sites, curves of homologous displacement (unlabeled 
ligand: rANF(99-126)) and heterologous displacement (unlabeled ligand: 
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des(18-22)rANF(4-23)NH2) were analyzed simultaneously. This combined 
fitting of two different experiments allowed the estimation of receptor 
density of B- and C-receptors and of their equilibration dissociation 
constants. 
RESULTS 
Binding Assay: Characterization of Receptor Binding 
Binding of 1 2 5 l - rANF to glomeruli and glomerular membranes was 
determined as a function of protein concentration, incubation time and 
temperature. As seen in Fig. 1 specific binding of ANF increased with 
increasing protein concentration, showing linearity between 5 MQ and 30 ^g 
for glomeruli as well as glomerular membranes. Incubation of glomeruli and 
glomerular membranes at 4°C and 22°C (Fig. 2) showed that binding of 
1 2 5 l - r A N F to glomerular membranes reached an equilibrium at both 
temperatures at 5 h which remained stable for a further 4 h. A quite similar 
binding curve was obtained with glomeruli. At 22°C an equilibrium occured 
after 4 h, at 4°C after 6 h. Nonspecific binding defined as the amount of 
1 2 5 l - r A N F bound in presence of 10~6 M unlabeled rANF(99-126) con-
tributed always less than 4% (glomeruli) and less than 3% (glomerular 
membranes) of the total radioactivity added. In relation to the total binding 
however, nonspecific binding amounted up to 35% for glomeruli and up to 
20% for glomerular membranes (Fig. 2). Higher specific binding (by about 
10%) exhibited by glomerular membranes as compared to glomeruli could 
be observed at 22°C as well as at 4°C. Binding experiments at 4°C 
however showed higher specific binding for glomeruli as well as for 
membranes by about 10% compared to binding curves done at 22°C (Fig. 
2). There was no significant degradation of 1 2 5 l - rANF during the incubation 
time of 5 h as determined by HPLC (data not shown). Based on these 
experiments further binding studies were performed at 4°C for 5h with 15 
Mg of glomerular protein. 
PROTEIN [ug] PROTEIN [pg] § 
c 
FIG. 1. Binding of 1 2 5 l-rANF(99-126) to rat glomeruli and glomerular % 
membranes as a function of protein concentration. Tissue preparations ° 
were incubated at 4°C for 5 h with 20 pM 1 Ä l - r A N F . g 
00 
FIG. 2. Binding of 1 Ä l - rANF(99-126) to rat glomeruli and glomerular 
membranes as a function of incubation time and temperature, respectively. 
The protein concentration was 15 /xg for each tube. 
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Confirmation of two distinct ANF Receptor Subtypes 
The binding of ^ 2 5 l - rANF to glomerular membranes was saturable in 
a biphasic fashion. Scatchard analysis of data from saturation experiments 
demonstrated the presence of two distinct ANF binding sites with high and 
low affinity (data not shown). 
Affinity cross-linking studies were employed to characterize the 
relative molecular weight (Mr) of both receptor types. The autoradiogramm 
of SDS-polyacrylamide gel electrophoresis-solubilized glomerular mem-
branes showed two distinct bands with a Mr of 130 kDa and 65 kDa, 
respectively. The specifity of ^ 2 5 l - rANF cross-linking was demonstrated by 
displacement with increasing concentrations of unlabeled rANF(99-126). 
The intensity of labeling of both receptors diminished in a dose-dependent 
manner and labeling was absent in presence of 10~6 M rANF (data not 
shown). 
Confirmation of two receptor populations present on glomerular 
membranes was furthermore achieved by several types of displacement 
experiments. As shown in Fig. 3 competitive binding of labeled and 
unlabeled rANF(99-126) clearly demonstrated receptor heterogeneity. The 
displacement of bound 1 2 5 l - r A N F by unlabeled des(18-22)rANF(4-23)NH2 
was used to estimate C-receptor density. In a further experimental 
approach competitive binding of labeled and unlabeled rANF(99-126) in 
presence of excess des(18-22)rANF(4-23)NH2 allowed selective saturation 
of C -receptors and therefore verification of a second class of receptors (B-
receptors) (Fig. 3). 
Quantification of ANF Receptor Types 
Data were obtained by displacement experiments from 10 animals. A 
representative displacement curve with both tissue preparations is 
demonstrated in Fig. 4. Table 1 shows the receptor density and affinity of 
B- and C-receptors calculated from glomeruli and glomerular membranes, 
respectively. There was no significant difference in receptor density or in 
affinity constants between glomeruli and glomerular membranes. 
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FIG. 3. Representative displacement binding curves of 1 2 5 l-rANF(99-126). 
30 /xg of glomerular membrane protein were incubated in presence of 
varying concentrations of unlabeled rANF(99-126) or des(18-22)rANF(4^ 
23)NHo and of rANF(99-126) in presence of excess concentrations (10" b 
M) of cfes(18-22)rANF(4-23)NH2. 
DISCUSSION 
The purpose of the present study was to define optimal conditions 
for the quantitative differentiation of glomerular B- and C-receptors for ANF. 
In a first step binding of 1 2 5 l - rANF was investigated under various con-
ditions. ANF binding to glomeruli and glomerular membranes as a function 
of time showed that equilibrium was reached between 4 and 5 h at 4°C 
B/T 
12 10 8 6 12 10 8 6 
-LOG CONC PEPTIDE [M] -LOG CONC PEPTIDE [M] 
FIG. 4. Representative displacement binding curves of '^l-rANF(99-126) 
to glomeruli and to glomerular membranes. Tissue preparations were 
incubated with varying concentrations of unlabeled rANF(99-126) or 
des(18-22)rANF(4-23)NH2. Results are expressed as bound-total (B/T) vs. 
total (unlabeled ligand). 
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TABLE 1 
Binding Properties of ANF Receptor Subtypes 
B-receptor C-receptor 
B max 
[fmol/mg prot.] 
Glomeruli 
Glom. Membr. 
71 
94 
37 
53 
K D 
[pM] 
43 ± 36 
52 ± 44 
B max 
[fmol/mg prot.] [pM] 
976 
966 
282 
167 
876 
307 
377 
36 
and 22°C. Studies on the time course of ANF binding to various renal 
tissues at 4°C and 22°C reported equilibration times between 60-90 min 
(15, 16) and 4 h (17, 18). The use of different assay buffers might account 
for these variations. 
After the demonstration of a linear relationship of specific binding 
and protein concentration, optimal conditions for binding assays were 
defined as follows: 4°C (higher specific binding), 5 h incubation time 
(equilibrium), 15 ^g protein (within the linear range). Under these con-
ditions glomerular membranes compared to glomeruli showed higher 
specific binding and less intra-assay variation of the measuring points done 
in triplicates. This finding may be due to a more homologous tissue 
preparation of glomerular membranes. 
In a second step the presence of two distinct ANF receptors on 
glomerular membranes was confirmed by saturation binding and by affinity 
cross-linking studies. Scatchard analysis of data from saturation ex-
periments was most consistent with a model for two separate classes of 
receptors, differing in their affinity and binding capacity. The auto-
radiogramm of SDS Polyacrylamide gel electrophoresis-resolved glo-
merular membranes revealed two labeled bands with molecular weights of 
130 kDa and 65 kDa, as reported for the B- and C-receptor, respectively 
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(10, 19, 20, 21). These two experiments most likely identified the two 
receptors as B- and C-receptors. 
In a third step we investigated a technique that would allow to 
quantitatively distinguish B- and C-receptors. It has been reported that B-
and C-receptors differ in their structural requirements for binding of ANF 
ligands (22, 23, 24). While B-receptors bind full-length disuifide-bridged 
ANF ligands only, C-receptors exhibit less stringent requirements and are 
able to bind truncated ANF analogues as well. Utilizing this property we 
chose an experimental approach of homologous (unlabeled ligand: 
rANF(99-126)) and heterologous displacement (unlabeled ligand: des(18-
22)rANF(4-23)NH2, binding to C-receptors only). Data analysis with the 
LIGAND program then allowed for a quantitative discrimination of both ANF 
receptor types. In both tissue preparations, glomeruli as well as glomerular 
membranes, the B-receptor constituted 7-9% of the total ANF binding sites. 
Other investigators reported ratios for B-receptors over the total number of 
receptors on glomeruli between 1 and 40% (4, 10). These variations 
probably depend on different ways of tissue preparation, purification and 
data analyzing techniques. Binding affinity constants seem to be less 
influenced by experimental maneuvers. Previous reports of K D values for 
B- and C-receptors of glomeruli and glomerular membranes are in 
agreement with our results (4,10). 
In conclusion, we have demonstrated that ANF binds to two 
separate types of receptors on glomerular tissue. We have determined 
appropriate conditions for selective displacement allowing to quantitatively 
differentiate B- and C-receptors and to determine their binding affinity 
constants. Since glomerular membranes exhibit higher specific binding and 
less intra-assay variation than glomeruli we favor using glomerular 
membranes for quantitative ANF binding studies. 
This method of competitive displacement with two different ligands 
should allow to investigate possible influences of various physiological and 
pathophysiological conditions on the binding properties of B- and C-
receptors for ANF (25). 
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